Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent personal assault (American Psychiatric Association, 2018). PTSD affects as many as one in four people who experience traumatic events, and contributes to marked functional disability, health impairment, and social dysfunction. People with PTSD may relive the event via intrusive memories, flashbacks, and nightmares; avoid anything that reminds them of the trauma; and have anxious feelings they didn’t have before (North, Hong and Downs, 2018).

GlobalData epidemiologists utilized national databases and robust peer-reviewed journal articles to build the forecast for the 12-month total prevalent cases of PTSD in the 7MM. GlobalData epidemiologists applied country-specific 12-month total prevalent cases of PTSD, wherever available, to each country’s population to obtain the number of estimated 12-month total prevalent cases.

The following data describes epidemiology of PTSD. GlobalData epidemiologists forecast an increase in the 12-month total prevalent cases of PTSD in the 7MM from 17,115,231 cases in 2018 to 17,846,569 cases in 2028, at an Annual Growth Rate (AGR) of 0.43% per year during the forecast period. The US will have the highest number of 12-month total prevalent cases of PTSD among the 7MM, while Japan will have the lowest.

Scope

The Post-traumatic stress disorder Epidemiology Report and Model provide an overview of the risk factors and global trends of Post-traumatic stress disorder (PTSD) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

The report includes a 10-year epidemiological forecast for the 12-month total prevalent cases of PTSD segmented by sex, and age (for ages 18 years and older) in these markets. The 12-month total prevalent cases of PTSD are further segmented by onset of disease (acute and chronic, and delayed onset).

The PTSD epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.

 The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

 The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The PTSD Epidemiology series will allow you to:

Develop business strategies by understanding the trends shaping and driving the global PTSD market.

Quantify patient populations in the global PTSD market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for PTSD therapeutics in each of the markets covered.

Understand magnitude of PTSD population by the onset of disease.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Post-Traumatic Stress Disorder: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Post-Traumatic Stress Disorder: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods: 12-Month Total Prevalence of PTSD

3.4.3 US

3.4.4 Forecast Assumptions and Methods: 12-Month Total Prevalence of PTSD by Onset of Disease

3.5 Epidemiological Forecast for PTSD (2018–2028)

3.5.1 12-Month Total Prevalent Cases of PTSD

3.5.2 Age-Specific 12-Month Total Prevalent Cases of PTSD

3.5.3 Sex-Specific 12-Month Total Prevalent Cases of PTSD

3.5.4 12-Month Total Prevalent Cases of PTSD by Onset of Disease

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of Analysis

3.6.3 Strengths of Analysis

4 Appendix

4.1 Bibliography

4.2 About the Authors

4.2.1 Epidemiologist

4.2.2 Reviewers

4.2.3 Global Director of Therapy Analysis and Epidemiology

4.2.4 Global Head and EVP of Healthcare Operations and Strategy

4.3 About GlobalData

4.4 Contact Us

4.5 Disclaimer

List of Tables

Table 1: Risk Factors and Comorbid Conditions Associated with PTSD

Table 1: Risk Factors and Comorbid Conditions Associated with PTSD

List of Figures

Figure 1: 7MM, 12-Month Total Prevalent Cases of PTSD, Both Sexes, Ages ≥18 Years, 2018 and 2028

Figure 2: 7MM, 12-Month Total Prevalence of PTSD ...

Figure 1: 7MM, 12-Month Total Prevalent Cases of PTSD, Both Sexes, Ages ≥18 Years, 2018 and 2028

Figure 2: 7MM, 12-Month Total Prevalence of PTSD (%), Men and Women, Ages ≥18 Years, 2018

Figure 3: 7MM, Sources Used and Not Used to Forecast the 12-Month Total Prevalent Cases of PTSD

Figure 4: 7MM, Sources Used to Forecast the 12-Month Total Prevalent Cases of PTSD by Onset of Disease

Figure 5: 7MM, 12-Month Total Prevalent Cases of PTSD, Both Sexes, Ages ≥18 Years, 2018

Figure 6: 7MM, Age-Specific 12-Month Total Prevalent Cases of PTSD, Both Sexes, Ages ≥18 Years, 2018

Figure 7: 7MM, Sex-Specific 12-Month Total Prevalent Cases of PTSD, Ages ≥18 Years, 2018

Figure 8: 7MM, 12-Month Total Prevalent Cases of PTSD by Onset of Disease, Both Sexes, Ages ≥18 Years, 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports